Arbutus BiopharmaRecent Data Breaches and Security Report

https://arbutusbio.com ᛫
Last updated October 26, 2018

Company Details

Company Overview

Arbutus Biopharma Corporation is a publicly traded (NASDAQ: ABUS) biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Vancouver, British Columbia and has research facilities in Warminster, Pennsylvania.

Valuation

$525,589,900

Employees

119

CEO

Location

Burnaby, BC, Canada.

Recent Data Breaches

Stay informed about the most recent data breaches affecting companies like Arbutus Biopharma

subscribe to data breach notifications

More Security Reports

OppenheimerFunds

New York, NY, United States.

Ambac Financial Group

Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's CSTAR Score ranges from 0 to 950. The higher the score, the more effective a company is in implementing good security practices.

Passed Checks

{{ passedCheck.passTitle }}

Failed Checks

{{ failedCheck.failTitle }}

View a free security report for Arbutus Biopharma

Get full security report ›

More Security Reports

OppenheimerFunds

New York, NY, United States.

Ambac Financial Group

See UpGuard In Action

Book a call with one of our specialists and we'll arrange a time for a demo.